Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Study Details
Study Description
Brief Summary
The purpose if the study is to determine whether improving sleep, especially slow wave or "deep" sleep, in older adults with osteoarthritis (OA) and insomnia reduces pain sensitivity and inflammatory responses to pain, and improves OA-related pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Insomnia treatment Cognitive Behavioral Therapy for Insomnia |
Behavioral: Cognitive Behavioral Therapy for Insomnia
6-week behavioral treatment for insomnia
|
No Intervention: Control
|
Outcome Measures
Primary Outcome Measures
- Change from baseline in minutes of time in slow wave sleep [baseline and 10 weeks]
- Change from baseline in relative power of delta EEG activity to index slow wave sleep activity [baseline and 10 weeks]
- Change from baseline in nociception flexion reflex threshold [baseline and 10 weeks]
- Change from baseline in electrocutaneous pain threshold [baseline and 10 weeks]
- Change from baseline in inflammatory cytokine responses to pain [baseline and 10 weeks]
- Change from baseline in Western Ontario and McMaster University OA Index [baseline and 10 weeks]
- Change from baseline in Knee Pain Scale score [baseline and 10 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
50-75 years of age (for women, post-menopausal)
-
Kellgren-Lawrence grade II radiographic evidence of OA affecting one or both knees
-
knee pain on most days for ≥ 6 months
-
self-reported disability due to knee pain for ≥ 2 of the following: walking, kneeling, ascending or descending stairs, or performing daily activities
-
willing and able to avoid all prescription and non-prescription, non-opiate pain medication for 48 hours prior to testing and all narcotic pain medication for 2 weeks prior to testing
-
meets research diagnostic criteria for sleep maintenance insomnia
Exclusion Criteria:
-
health conditions with immunological components or undergoing or taking immunosuppressive therapies
-
conditions contraindicated for or potentially limiting ability to conduct NFR and/or cold pressor test (e.g. Raynaud's syndrome; seizures; prior MI; respiratory conditions; leg/hip nerve damage; BMI ≥ 32)
-
sleep disorders other than insomnia
-
dementia or cognitive impairment
-
history of schizophrenia or bipolar I disorder; current or recent history (within 3 months) of major psychiatric disorders
-
current depressive symptomatology or current suicidality
-
active substance dependence
-
untreated hypertension
-
use of antidepressants (stable use for 3 months okay), antipsychotics, mood stabilizers, sedative-hypnotics, opiate analgesics
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Rochester Medical Center | Rochester | New York | United States | 14642 |
Sponsors and Collaborators
- University of Rochester
- National Institute on Aging (NIA)
Investigators
- Principal Investigator: Kathi L. Heffner, PhD, University of Rochester
- Principal Investigator: Wilfred Pigeon, PhD, University of Rochester
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RSRB00044088
- R21AG041942-01A1